Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · IEX Real-Time Price · USD

0.990

-0.005 (-0.52%)

At close: Jul 2, 2024, 4:00 PM

1.020

+0.030 (3.03%)

After-hours: Jul 2, 2024, 6:01 PM EDT

Oncolytics Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2001
Market Capitalization	75	94	95	76	101	119	Upgrade
Market Cap Growth	7.20%	-0.88%	24.41%	-24.16%	-15.47%	341.15%	Upgrade
Enterprise Value	47	68	72	45	77	109	Upgrade
PE Ratio	-	-4.52	-5.24	-3.72	-5.71	-4.71	Upgrade
PB Ratio	3.27	4.55	4.92	2.71	5.19	-1447.15	Upgrade
P/FCF Ratio	-3.81	-4.40	-5.56	-4.31	-5.81	-7.84	Upgrade
P/OCF Ratio	-3.82	-4.41	-5.58	-4.36	-5.82	-7.84	Upgrade
EV/EBITDA Ratio	-2.85	-3.33	-4.04	-2.22	-4.43	-4.37	Upgrade
EV/EBIT Ratio	-2.80	-3.28	-3.98	-2.18	-4.34	-4.30	Upgrade
EV/FCF Ratio	-2.80	-3.19	-4.21	-2.52	-4.42	-7.15	Upgrade
Debt / Equity Ratio	0.05	0.02	0.01	0.02	0.02	-4.69	Upgrade
Debt / EBITDA Ratio	-0.04	-0.02	-0.02	-0.03	-0.02	-0.02	Upgrade
Debt / FCF Ratio	-0.04	-0.01	-0.02	-0.03	-0.02	-0.03	Upgrade
Quick Ratio	7.24	8.24	8.28	15.66	11.56	1.26	Upgrade
Current Ratio	8.14	9.01	9.05	16.69	12.45	1.47	Upgrade
Return on Equity (ROE)	-110.90%	-106.20%	-82.30%	-61.90%	-96.60%	-1032.60%	Upgrade
Return on Assets (ROA)	-74.40%	-72.90%	-61.70%	-50.40%	-66.80%	-195.70%	Upgrade
Return on Capital (ROIC)	-148.50%	-120.74%	-100.18%	-71.38%	-101.21%	-5114.86%	Upgrade
Earnings Yield	-37.56%	-22.14%	-19.07%	-26.89%	-17.52%	-21.21%	Upgrade
FCF Yield	-37.47%	-22.70%	-17.97%	-23.23%	-17.20%	-12.76%	Upgrade
Buyback Yield / Dilution	-20.69%	-16.53%	-8.44%	-32.66%	-82.22%	-38.22%	Upgrade
Total Shareholder Return	-20.69%	-16.53%	-8.44%	-32.66%	-82.22%	-38.22%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).